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Abstract
Phenolic compounds are the biggest group of phytochemicals, and many of them have 
been found in plant‐based foods. Polyphenol‐rich diets have been linked to many health 
benefits including cancer. The potential anti‐carcinogenic mechanisms of action that 
have been so far identified for phenolic compounds, as well as the feasibility reports 
occurred in vivo. In general terms, under the oxidative stress, polyphenols could act in 
those cellular mechanisms by participating in the modulation of the redox status and on 
multiple key elements in intracellular signal transduction pathways related to cell prolif‐
eration, differentiation, apoptosis, inflammation, angiogenesis and metastasis. A protec‐
tive role of polyphenols against carcinogenesis is supported by many studies carried out 
on animal models and different mechanisms of action have been proposed to explain 
such protective effects. Studies performed in animals have demonstrated that phenolic 
components can prevent and/or slow down the initiation‐progression of different types 
of cancers. They act through the regulation of cell signal transduction and gene expres‐
sion and exhibit either up or down regulation of genes controlling tumor development.
Keywords: phenolic compounds, carcinogenesis, apoptosis induction, tumor metastasis 
and angiogenesis
1. Introduction
Cancer is a broad term used to describe a large group of disorders characterized by an uncon‐
trolled growth of abnormal cells. These cells have the ability to escape surveillance by the 
immune system, to multiply indefinitely, to invade nearby tissues and to spread to distant 
sites of the body forming metastases [1]. Most cancers fall into one of the four main groups: 
carcinomas, sarcomas, leukemias or lymphomas. Carcinomas are cancers of epithelial ori‐
gin. They represent approximately 90% of human malignancies. Sarcomas, which are rare 
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in humans, refer to solid tumors deriving from connective tissues, such as muscle, bone, 
cartilage and fibrous tissue. Cancers arising from the blood cells precursors and from cells 
of the immune system are called leukemias and lymphomas, respectively. Together, these 
two account for about 8% of human malignancies. Cancers can further be classified according 
to the topography of the primary tumor into several types, such as colon cancer, breast cancer, 
lung cancer, etc. [2].
1.1. Worldwide cancer incidence and mortality
Cancer ranks among the leading causes of morbidity in the world. According to GLOBOCAN 
2012, the latest online database produced by the International Agency for Research on Cancer 
(IARC): 14.1 million new cancer cases occurred in 2012 worldwide. About 8 million (57%) were 
in economically developing countries, in which about 82% of the world's population reside 
[3]. The global incidence of cancer is expected to increase to 22.2 million by 2030 (an increase 
of 57% from 2012), based only on projected demographic changes and unchanged cancer inci‐
dence rates [4]. The most common malignancy worldwide is lung cancer accounting for 1.8 
million new cases in 2012, followed by breast cancer (1.7 million new cases), colorectal cancer 
(1.4 million new cases), prostate cancer (1.1 million new cases), stomach cancer (951,000 new 
cases) and liver cancer (782,000 new cases) [5].
The overall age standardized cancer incidence rate in 2012 was almost 25% higher in men than 
in women, with rates of 205 and 165 per 100,000, respectively [3]. Lung, prostate, colorectal, 
stomach and liver cancer are the most common types of cancer in men, while breast, colorec‐
tal, lung, cervix and stomach cancer are the most common among women [5].
In terms of mortality, cancer is the second most common cause of death worldwide after 
cardiovascular diseases. The total number of cancer deaths in 2012 was 8.2 million, of these 
2.9 million (35%) occurred in economically developed countries and 5.3 million (65%) in less 
developed countries [3]. Lung cancer remains the leading cause of death worldwide with 1.6 
million deaths in 2012, followed by liver cancer (745,000 deaths), stomach cancer (723,000 
deaths), colorectal cancer (694,000 deaths) and breast cancer (522,000 deaths) [5].
1.2. Cancer development process and prevention
Cancer is a multifactorial disease; many exogenous factors (such as poor diet, tobacco smok‐
ing, chemicals, radiation and infectious organisms) and endogenous factors (such as inher‐
ited mutations, hormones and immune conditions) contribute to its aetiology [6–8]. These 
factors may act together or in sequence to trigger and/or promote cancer development. The 
latter, also known as “carcinogenesis” or “tumorigenesis”, is a complex multistep process 
resulting from the progressive accumulation and functional cooperation of genetic and epi‐
genetic alterations that eventually allow cells to break free from the tight network of regula‐
tion systems that maintain the homeostatic balance between proliferation and programmed 
cell death [1].
The genetic alterations can be the result of endogenous processes, such as errors in DNA rep‐
lication, intrinsic chemical instabilities of certain DNA bases or attacks by free radicals gen‐
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erated during metabolism. DNA damage can also result from interactions with exogenous 
agents, such as radiation and chemical carcinogens. Under normal conditions, human cells 
have the ability to overcome these alterations thanks to DNA repair genes, apoptosis and cell 
buffer systems. Whenever these cell protection mechanisms are constitutionally altered or the 
DNA attack overtake the capacities of a normal cell, permanent mutations occur. These muta‐
tions could activate genes involved in cell growth and proliferation (oncogenes) or inactivate 
genes involved in cell senescence and apoptosis (tumour suppressor genes). If the permanent 
mutations occur in DNA repair genes as well, they will facilitate the acquisition of additional 
mutations [9, 10].
Cancers are also a consequence of epigenetic alterations, which are by definition, persistent 
and heritable changes in gene expression that result from modifications of chromatin struc‐
ture without modification of the cell's DNA sequence. This can occur with DNA methylation 
and histone modifications [11]. This type of alterations along with the genetic ones lead to 
the transformation of a normal cell into a neoplastic cell with six essential physiological dys‐
functions that collectively dictate its malignant growth: self‐sufficiency in growth signals, 
insensitivity to growth inhibitory (antigrowth) signals, evasion of programmed cell death 
(apoptosis), limitless replicative potential, sustained angiogenesis and tissue invasion and 
metastasis [1].
The multistage nature of the carcinogenesis process, the presence of precursor lesions at the 
intermediate stages between normal and malignant cells, the slow growth of tumors and, the 
long latency, generally for decades before the diagnosis is established indicate that the car‐
cinogenic process could be blocked or delayed and that the development of invasive cancers 
could be prevented [12].
Many scientists are focusing their researches on finding new strategies for cancer prevention. 
One strategy with promising potential is “chemoprevention” that has been defined by Sporn 
in 1976 as “the use of natural, synthetic or biological agents to reverse, suppress or prevent 
either the initial phases of carcinogenesis or the progression of premalignant cells to invasive 
disease” [13, 14].
Several epidemiologic studies suggest that regular consumption of fruits and vegetables sig‐
nificantly reduces the risk of different cancers. The beneficial effects of this type of diet are in 
part attributed to their content of phenolic compounds, which have shown promising anti‐
tumour properties in both in vitro and in vivo studies [15–17].
2. Phenolic compounds
2.1. Classification
Phenolic compounds, widely distributed secondary metabolites in plants, form a group of 
molecules with highly diversified chemical structures. They can be classified according to 
their carbon skeleton into the following main classes: simple phenols, phenolic acids, flavo‐
noids, tannins, lignans, lignins, curcuminoids, coumarins and stilbenes as shown in Figure 1.
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Phenolic acids include hydroxybenzoates (C6–C1) and hydroxycinammates (C6–C3). Hydroxy‐
benzoic acids are represented mainly by gallic and ellagic acids, whereas the major hydroxycinnamic 
acids are caffeic and ferulic acids.
Flavonoids are the largest group of phenolic compounds containing two aromatic rings linked 
by a three atoms of carbon bridge (C6–C3–C6). They include mainly flavones, isoflavones, flavo‐
nols, flavans, flavanones and anthocyanidins [18]. Rutin, quercetin‐3‐O‐rutinoside, is the glyco‐
side of the flavonol quercetin. Epigallocatechin‐3‐gallate (EGCG), a type of the flavanol catechin, 
is the ester of epigallocatechin and gallic acid. Silymarin is a flavonolignan composed mainly by 
silybin (A and B), isosilybin (A and B), silychristin (A and B) and silydianin [19].
Tannins are divided into two different chemical groups, hydrolysable tannins that are 
polymers of gallic or ellagic acids and condensed tannins that are polymers of catechins or 
epicatechins.
Curcumin (C6–C7–C6) is a diferuloylmethane belonging to the group of curcuminoids [20].
2.2. Food sources of phenolic compounds
Phenolic compounds are widespread in food. Fruits and vegetables, such as apples, cherries, 
oranges, citrus, grapes, berries, peaches, cereals and tomatoes are particularly rich in poly‐
phenols as shown in Table 1.
2.3. Phenolic compounds as antioxydants
Phenolic compounds have received increasing interest in the human health due to their ben‐
efit effects against several diseases like cancers attributed in particular to their antioxidant 
activity [29, 30]. Multiple investigations support that oxidative stress plays a key role in the 
cancer occurrence and other health problems induced by the excess production of the reactive 
Figure 1. Main classes of phenolic compounds.
Phenolic Compounds - Biological Activity196
oxygen species (ROS) that includes many radicals, such as superoxide (O‐2), hydroxyl (OH─), 
hydroperoxyl (OOH─), peroxyl (ROO─), alkoxyl (RO─), nitric oxide (NO─) and peroxynitrite 
anion (ONOO─). The ROS may cause oxidative damage to vital biomolecules, such as DNA, 
lipids and proteins [31].
Phenolic compound Carbon skeleton Food source References
Phenolic acids
Gallic acid
Ellagic acid
Hydroxybenzoates
p‐Hydroxybenzoic acid 
protocatechuic acid
Vanillic acid
Syringic acids
C6–C1 Berries, particularly raspberries, 
strawberries, and blackberries, grape juice 
and cereals
[19–21]
Hydroxycinammates
p‐Coumaric, caffeic, ferulic 
acids
Hydroxycinnamic 
derivatives
Chlorogenic acid
Curcumin
C6–C3 Blueberry, cherry, sweet pear, apples 
(chlorogenic acid), orange, potato, grape 
fruit, coffee beans, plum, tomatoes, grape, 
wheat bran, kiwis, cereal grains (ferulic 
acid), apricots, carrots, cereals, citrus fruits, 
oilseeds, peaches and spinach
[20–23]
Flavonols
Quercetin
Kaempferol
Myricetin
Isorhamnetin
C6–C3–C6 Onions Allium cepa, apples, plums, 
cranberries, strawberries, grapes, kale, 
broccoli, celery stalks, tomatoes, buckwheat, 
endive, leeks, lettuce, olive, pepper, red 
wine, green tea and grape juice
[19–27]
Flavones
Apigenin
Luteolin
C6–C3–C6 Celery, parsley, artichoke, green olive, 
sweet peppers, onion, garlic, chamomile tea, 
Thai chili, citrus fruits, celery and spinach
[19–21, 23, 24, 26]
Flavan‐3‐ols
(+)‐Catechin
(‐)‐Epicatechin
C6–C3–C6 Tea, apricots, sour cherries, grapes and 
blackberries, apples, peaches nectarines, 
barley (cereal), plums, nuts, red wine and 
chocolate
[19–27]
Flavanones
Naringenin
Hesperetin
Eriodictyol
Minor compounds
Sakuranetin
Isosakuranetin
C6–C3–C6 Citrus fruits: orange, lemons, grapes and 
tomatoes (Naringenin)
[19, 21, 23, 24, 26, 27]
Anthocyanidins
Cyanidin
Delphinidin
Petunidin
Peonidin
Pelargonidin
Malvidin
C6–C3–C6 The most widespread anthocyanidin in 
fruits is cyanidin‐3 glucoside
Grapes, blueberry, red onions, blood 
oranges and red wine
Blackcurrant, blackberry, and elderberry 
(only cyanide)
[19, 21, 23, 24, 26, 27]
Isoflavones
Genistin
Daidzein
Glycitein
C6–C3–C6 Soybeans and soy products are almost the 
sole dietary source of isoflavones
Found also in small amounts in chickpeas
[19–24, 26, 27]
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Phenolic compounds may suppress ROS formation by different mechanisms, such as inhibit‐
ing some enzymes like xanthine oxidase responsible for superoxide ion production; chelating 
trace elements like metals, such as free iron and copper ions involved in the formation of 
radicals and scavenging radical species by hydrogen donation. The antioxidant capacity is 
related to the number and the position of hydroxyl groups in the phenolic compound [24, 25].
3. Polyphenols in prevention of cancer
Natural polyphenols are naturally occurring compounds found largely in the fruits, vegeta‐
bles and are the most antioxidants in human diets, and their radical scavenging activities are 
related to substitution of hydroxyl groups in the aromatic rings of phenolic. They have been 
considered powerful antioxidants in vitro and proved to be more potent antioxidants than 
Vitamin C and E and carotenoids [32]. Phenolic compounds are also capable of scaveng‐
ing free superoxide radicals, reducing the risk of cancer and protecting biological systems 
against the harmful effects of oxidative processes on macromolecules, such as carbohydrates, 
proteins, lipids and DNA [33]. It was found that in addition to their primary antioxidant 
activity, this group of compounds displays a wide variety of biological functions which are 
Phenolic compound Carbon skeleton Food source References
Stilbenes
Resveratrol
C6–C2–C6 Red wine and peanuts
Also found in berries, red cabbage, spinach, 
grapes, berries, plums and pine nuts
[19, 21–23]
Piceatannol
Astringin
Brazilian red wines [19]
Lignan
Secoisolariciresinol
Matairesinol
Medioresinol
Pinoresinol
Lariciresinol
(C6–C3)2 Flaxseed is the richest sourceBuckwheat, sesame seed, rye and wheat
[21–23]
Tannins
Condensed tannins
Catechin polymers
Epicatechin polymers
(C6–C3–C6)
n
Lentils, pear, grapes, peaches, plums, 
mangosteens, pears, red and white wine 
and apple juice
[22, 30]
Hydrolyzable tannins
Ellagitannins
Punicalagin
Casuarictin
Strawberries, blackberries, raspberries, 
walnuts, pecans pomegranate bark, leaf and 
the fruit husk
[20, 21, 23, 28]
Gallotannins Mangoes
Coumarins
Umbelliferone
Aesculetin
C6–C3 Carrots, celery, citrus fruits, parsley and 
parsnips
[21]
Table 1. Food sources of some phenolic compounds.
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mainly related to modulation of carcinogenesis. Furthermore, prevention of cancer is one of 
the most documented biological properties of the polyphenols. The effects of polyphenols 
on human cancer cell lines are protection and reduction of the number of tumors or their 
growth [34]. Mechanisms of anti‐cancer effects of polyphenols, found in fruits, vegetables 
and spices representing parts of daily nutrition, have been considered. These compounds 
may be the basis for development of cancer preventive preparations. Several studies in 
extracts or isolated polyphenols from different plant food reported in a number of cancer cell 
lines including different evolutionary stages of cancer. Extracts prepared from blackberry, 
raspberry, blueberry, cranberry, strawberry as well as the isolated polyphenols from straw‐
berry mainly like anthocyanins, kaempferol, quercetin, esters of coumaric acid and ellagic 
acid, have nutraceutical properties against tumor growth and cancer. They have revealed to 
be more effective to inhibit the growth of human oral (KB, CAL‐27), breast (MCF‐7), colon 
(HT‐29, HCT‐116) and prostate (LNCaP, DU‐145) tumor cell lines in a dose‐dependent man‐
ner with various sensitivity between cell lines [35, 36]. Many studies have focused on the 
antioxidative effects of phenolic compounds and it is suggested that its potential physiologi‐
cal effects for the protection and treatment of cancer and cardiovascular diseases come from 
its antioxidant activity. According to Ref. [37], phenolic compounds can block carcinogen‐
esis initiation by inactivation of exogenous or endogenous genotoxic molecules including 
reactive oxygen species. Another mechanism consists in inhibition of activity and synthesis 
of carcinogen‐metabolizing enzymes. Polyphenols activate phase I enzymes (cytochrome 
P450) to detoxify molecules procancérogènes [38, 39]. Many polyphenols, such as quercetin, 
catechins, isoflavones, lignans, flavanones, ellagic acid, red wine polyphenols, resveratrol or 
curcumin, showed protective effects in some cancerous models by different mechanisms. All 
the mechanisms of action of phenolic compounds against cancer are summarized in Table 2.
Dietary polyphenols Protective effects and mechanisms Conditions Level
Hydroxytyrosol Inhibiting cell proliferation In human promyelocytic In vitro
Inducing apoptosis by arresting the cells in the 
G0/G1 phase with a concomitant decrease in 
the cell percentage in the S and G2/M phases
Resveratrol Inhibiting cell proliferation and down 
regulating telomerase activity
In human colon tumor 
cells
In vitro
Inducing apoptosis mediated by p53‐
dependent pathway
In HepG2 cells In vitro
Inhibiting cell proliferation by interfering 
with an estrogen receptor‐α‐associated PI3K 
pathway
In estrogen‐responsive 
MCF‐7 human breast 
cancer cells
In vitro
Suppressing COX‐2 expression by blocking the 
activation of MAPKs and AP‐1
In dorsal skin of female 
ICR mice
In vitro
Decreasing the expression of COX‐1, COX‐2, 
c‐myc, c‐fos,c‐jun, transforming growth 
factor‐β‐1 and TNF‐α
In mouse skin Ex vivo
Inhibiting oncogenic disease through the 
inhibition of protein kinase CKII activity
In HeLa cell lysates In vitro
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3.1. Natural polyphenols and apoptosis targeting in cancer cells
In chemoprevention, suppression of cell proliferation and induction of differentiation and 
apoptosis are important strategies, with the induction of programmed cell death currently 
considered as one relevant target in a preventive track. Apoptosis (programmed cell death) 
is the process by which cells trigger their self‐destruction in response to a signal. It is defined 
by a set of characteristic morphological features such cell shrinkage, chromatin condensation 
and DNA fragmentation due to endonuclease activation, cell budding and apoptotic body 
formation and loss of the membrane integrity [41]. Programmed cell death plays an important 
role in the maintenance of biological cells and systems. Apoptosis can be triggered through 
two main pathways: extrinsic and intrinsic. Extrinsic factors could act in the activation of cell 
surface receptors, such as tumor necrosis factor (TNF)‐alpha that leads to the induction of cas‐
pase‐8. Intrinsic pathways involved internal cell signaling primarily through the mitochon‐
dria. Regulation system of apoptosis are also induced in the mitochondria on the intrinsic 
pathway by several families of proteins, including small mitochondrial‐derived activator of 
caspases (SMACs), inhibitor of apoptosis proteins (IAPs) and the B‐cell lymphoma 2 protein 
(Bcl‐2) family, as well as membrane polarity and integrity [42]. Other key molecule in apop‐
tosis regulation is the transcription factor p53. The main role of p53 is the protection against 
genomic instability and tumorigenesis. Functionally promotes survival by activating check‐
points and facilitating damage repair, sustained proliferation blocking and apoptosis [43]. 
Many dietary phenolic compounds, including quercetin, EGCG [(‐)‐epigallocatechin‐3‐gal‐
late], apigenin, chrysin, silymarin, curcumin, ellagic acid and resveratrol, may block carcino‐
genesis through induction of apoptosis. They may induce apoptosis via multiple mechanisms. 
Dietary polyphenols Protective effects and mechanisms Conditions Level
Inhibiting the Ca(2+)‐dependent activities of 
PKCα and PKCβI
On the activities of PKC 
isozymes
In vitro
Inhibiting nitrobenzene(NB)‐DNA adducts In male Kunming mice 
adducts
In vivo
Chlorogenic acid Inhibiting the formation of DNA single strand 
breaks
In supercoiled pBR322 
DNA
In vitro
Quercetin
Luteolin
Blocking EGFR tyrosine kinase activity In MiaPaCa‐2 cancer cells In vitro
Myricetin
Apigenin
Quercetin
Kaempferol
Inhibiting human CYP1A1 activities
Inhibiting the formation of diolepoxide 2(DE2) 
and B[a]P activation
On 7‐ethoxyresorufin 
o‐deethylation
In vitro
Silymarin
Hesperetin
Quercetin
Daidzein
Interacting with p‐glycoprotein and modulating 
the activity of ATP‐binding cassette transporter, 
breast cancer resistance protein (BCRP/ABCG2)
In two separate BCRP‐
overexpressing cell lines
In vitro
EGCG Inhibiting telomerase In human cancer cells In vitro
In nude mice models In vivo
Table 2. Anti‐mutagenic/anti‐carcinogenic properties of polyphenols [40].
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In vitro studies show that EGCG, curcumin or resveratrol sensitize LNCaP prostate cancer 
cells to TNF‐related apoptosis‐inducing ligand (TRAIL)‐mediated apoptosis through modu‐
lation of the extrinsic apoptotic pathway [44, 45]. Furthermore, apoptosis intrinsic pathway 
could be triggered by phenolic compounds. Resveratrol induces apoptosis through the intrin‐
sic pathway in prostate cancer‐derived cell lines by activating caspases‐9/3 and by changing 
the Bax/Bcl‐2 ratio [46]. Apoptosis may be also induced through activation of proapoptotic 
proteins (e.g. caspases, proapoptotic Bcl‐2 family members) and/or inhibition of antiapop‐
totic proteins (e.g. Bcl‐2, Bcl‐xL and survivin) [41]. Interestingly, a synergistic effect has been 
reported to induce apoptosis by combination of drugs and/or natural phenolics. In this line, 
(‐)‐epicatechin (EC) showed a major synergistic effect on the induction of apoptosis in gastric 
cancer MKN‐45 cells treated with epigallocatechin‐3‐gallate [47]. Similarly, the combination 
of curcumin with (‐)‐epicatechin increased the inhibition of cell growth as compared to cur‐
cumin or EC alone, as well as the apoptosis rate and the expression of related genes to the 
programmed cell death, such as growth arrest DNA damage 153/45 (GADD153/45) in PC‐9 
cells [48]. Hexameric procyanidins inhibited the deoxycholic acid (DOC)‐induced cytotoxicity 
and partly delayed the DOC‐induced Caco‐2 cell apoptosis [49]. In the same way, curcumin 
suppresses Caco‐2 proliferation partially via activation of the mitochondrial apoptotic path‐
way and cell cycle retardation [50].
3.2. Antiproliferative effect
Suppression of cell proliferation and induction of differentiation and apoptosis are relevant 
strategies in preventive approaches. Deregulated cell cycle and resistance to apoptosis are 
hallmarks of cancer. The activity of the transcription factor nuclear factor‐kappa B (NF‐κB), 
responsible for the activation of many genes involved in cell proliferation, is closely linked to 
the redox status of cells. Indeed, NF‐κB is part of a family of dimeric proteins (p50/p65). In the 
absence of stimulation, NF‐kB is localized in the cytoplasm and is associated with its natural 
inhibitor IκB (inhibitor of NF‐κB). ROS production (H
2
O
2
, superoxide anion and the hydroxyl 
radical) induces phosphorylation of IκB causing its ubiquitination and degradation by the 
proteasome. NF‐κB is activated and translocated into the nucleus. At this stage, many genes 
(about 200) will be active [51]. Moreover, a number of human cancers, including breast can‐
cer, non‐small cell lung carcinoma, thyroid cancer, T‐ or B‐lymphocyte leukemia, melanoma, 
colon cancer, bladder cancer and several virally induced tumors have been characterized by 
constitutive NF‐κB activity and the inhibition of NF‐κB abrogates tumor cell proliferation [52, 
53]. Indeed, it has been postulated that some natural plant product anticancer effects are due 
to its capacity to inactivate NF‐κB‐dependent signaling. Many phenolic compounds including 
resveratrol [54], curcumin [55] and (‐)‐epigallocatechin‐3‐gallate [56] inhibit IKK‐mediated 
IκB phosphorylation by stimulating the retention of NF‐κB in the cytosol and its subsequent 
inactivation. Other studies demonstrate the ability of flavonoids as NF‐κB inhibitors and their 
role in preventing NF‐κB signaling pathway‐mediated disorders. It is identified that apigen, 
quercetin, kaempferol, rutin is a potent inhibitor of NF‐κB, which may perform a pivotal 
function in the regulation of cell growth, apoptosis and the regulation of the cell cycle [57–59]. 
Overall, the results indicated that flavonoids suppress the activation of NF‐κB and NF‐κB‐
regulated gene expression, leading to enhancement of apoptosis. This provides the molecular 
basis for the ability of polyphenols to act as an anticancer.
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3.3. Effects on angiogenesis and metastasis
Angiogenesis, the formation and growth of new blood vessels from preexisting microvas‐
culature, is a key stage in tumor growth, invasion and metastasis [41], many proteins have 
been identified in humans as activators of angiogenesis, among them, fibroblast growth factor 
(FGF), interleukin 8 (IL‐8), the platelet‐derived epidermal growth factor, transforming growth 
factor α (TGFα), the vascular endothelial growth factor (VEGF) and small molecules, such as 
adenosine, prostaglandin E and tetrahydrofolate (THF) [60]. According to many in vitro stud‐
ies, VEGF and FGF‐β appear to be the most important factors responsible for tumor growth 
and are produced by many types of cancer cells as well as normal cells [61]. Polyphenols 
can act as suppressing agents and inhibit the formation and growth of tumors from initi‐
ated cells; they inhibit cell proliferation in vitro [62]. Moreover, polyphenols, such as those 
of green tea, can also inhibit angiogenesis and, therefore, limit the growth of the tumors 
[63] or prevent tumor invasion through inhibition of the matrix metalloproteinases [64]. (+)‐
Catechin‐inhibited tumour‐specific angiogenesis by regulating the production of pro‐ and 
anti‐angiogenic factors, such as pro‐inflammatory cytokines, nitric oxide, VEGF, IL‐2 and tis‐
sue inhibitor of metalloproteinase‐1 [65]. Several studies report a selective effect of phenolic 
compounds in inhibiting angiogenesis in cancer cells. Thus curcumin, baicalin and resveratrol 
can also inhibit the angiogenic factor VEGF in tumor cells in culture [66–68]. On the other 
hand, quercetin inhibits angiogenesis through multiple mechanisms, including interaction 
with the cox‐2 and lipoxygenase‐5 enzymes, EGFR, the HER2 intracellular signalling pathway 
and the NF‐κB nuclear transcription protein [69]; furthermore, it has been shown that proan‐
thocyanidins added to mice with tumor xenografts reduced VEGF secretion, which resulted 
in reduced intratumoral microvasculature [70]. Previous studies reported that the chemical 
modification of (‐)‐epicatechin by its acylation improved the anti‐cancer and anti‐angiogenic 
activities of this flavanol [71].
The tissue invasion and metastasis formation require that tumor cells acquire the ability to 
migrate to other tissue and to invade them. This involves changing some cellular functions 
(cell adhesion) and the modification of the expression of certain genes, such as those encod‐
ing metalloproteinases degrading the extracellular matrix (MMP) or molecules adhesion [72]. 
Because metastasis occurs through a multistep process, dietary polyphenols have also been 
reported to interfere with cancer cell adhesion and movement processes through various 
mechanisms. Polyphenols, such as curcumin, apigenin, quercetin and catechin, have been 
reported to be chemopreventive through their anti‐proliferative, anti‐metastatic and/or anti‐
invasive properties [73, 74]. Resveratrol has been shown to inhibit cell migration/invasion and 
metastasis in several types of cancer, including breast cancer [75]. In addition, it was reported 
that Interleukin 6 (IL‐6) and its major effector, the signal transducer and activator of transcrip‐
tion 3 (STAT3), are part of an important inflammation‐associated pathway in malignancies [76] 
and metastasis [77] in different types of cancer. Resveratrol might be a potential agent chemo‐
sensitization on several types of cancer. This ability would be explained by the regulation of 
many signaling molecules including drug transporters, cell proliferation regulators, members 
of the NF‐κB signal transducer and activator of transcription 3 (STAT3) signaling pathways 
[78]. CD44 and CD54 played an important role in tumor metastasis by the mutual adhesion 
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and interaction between cancer cells and vascular endothelial cells [79]. Tea polyphenols, 
known as catechins, have effects on cancer prevention, inhibition and anti‐metastasis. Recent 
studies reported their role in the blockage of adhesion of lung carcinoma cell lines to endothe‐
lial cells is related to CD44 and CD54. The mechanism of tea polyphenol prevention of human 
lung carcinoma metastasis might be through inhibiting adhesion molecule expression to 
block cancer cell adhesion [80]. In breast cancer, curcumin exerts a strong anti‐invasive effect 
on estrogen receptor (ER)‐negative MDAMB231 cells through the down regulation of nuclear 
factor κB and activator protein‐1 (NF‐kB/AP 1) transcription factors dependent MMP‐1 and ‐2 
expression, the up regulation of TIMP‐1 (metallopeptidase inhibitor‐1), and the inhibition of 
VEGF and b‐FGF [81]. In addition, caffeic acid is a widespread phenolic acid exerts an effec‐
tive inhibition of the in vitro invasion of PC3 cells in prostate cancer [82]. Quercetin has also 
been widely investigated for its potential to inhibit both cellular migration and the invasion of 
cancer cells. Mechanistically, quercetin may inhibit cellular migration and invasion through 
the deactivation of matrix metalloproteinases‐2 (MMP‐2) and/or matrix metalloproteinases‐9 
(MMP‐9) [83]. Recent study showed that polyphenol enrichment of a blueberry preparation 
by fermentation increases its chemopreventive potential by protecting mice against tumor 
development, inhibiting the formation of cancer stem cells and reducing lung metastasis [84]. 
Indeed, the cytoprotective and anticancer action of dietary in‐taken natural polyphenols has 
for long been attributed only to their direct radical scavenging activities. Quercetin has been 
reported to possess anticancer property against benzo‐pyrene‐induced lung carcinogenesis 
in mice, an effect attributed to its free radical scavenging activity [85]. The anti‐carcinogenic 
effects of resveratrol appear also to be closely associated with its antioxidant activity [86].
4. Conclusion
Cancer has become in the recent decades one of the leading causes of death worldwide. 
The search for effective prevention has become a priority for the basic and clinical science. 
Polyphenols have been proposed as alternative therapy and shown effective in cancer treat‐
ment especially when consumed in synergistic mixtures. It has been already demonstrated 
that polyphenols are able to exert differential effects on tumor cells. Their action can be attrib‐
uted not only to their ability to act as antioxidants but also to their ability to interact with 
basic cellular mechanisms. Polyphenols, such as resveratrol, EGCG, curcumin and quercetin, 
have been shown to promote extrinsic and intrinsic apoptosis induction in different types of 
cancers (e.g. colon, lung, prostate, breast, melanoma or leukemia). Others studies performed 
in animals reported that phenolic components can prevent and/or slow down the initiation‐
progression of different types of cancers, such as cancer of prostate, liver, colon, leukemia, 
etc. Polyphenols can also act as suppressing agents, and inhibit the formation and growth of 
tumors from initiated cells; they inhibit cell proliferation in vitro. However, the exact mecha‐
nisms of actions are not fully understood and many properties remain unclear, require further 
consideration. These experimental and hypothetical data evince the need to perform further 
studies to understand the differential mechanisms of the polyphenols on cancer cells, which 
could contribute to find selective targets in cancer treatment.
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